151 related articles for article (PubMed ID: 9628608)
1. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
Gesenberg A; Sintermann R
J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
[TBL] [Abstract][Full Text] [Related]
2. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
3. [Outcome analysis of the urethral stent (Memotherm®)].
Sakamoto H; Matsuda A; Arakaki R; Yamada H
Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
[TBL] [Abstract][Full Text] [Related]
4. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
[TBL] [Abstract][Full Text] [Related]
5. [Initial experiences with the Memotherm Stent in treatment of benign prostatic hyperplasia].
Gottfried HW; Schimers HP; Gschwend J; Brändle E; Hautmann R
Urologe A; 1995 Mar; 34(2):110-8. PubMed ID: 7538708
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
7. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of bladder neck obstructions by the Memotherm stent].
Choquenet C; Kechaou M; Ortega JC
Prog Urol; 2003 Feb; 13(1):79-84. PubMed ID: 12703358
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and complications of intraprostatic prosthesis in the treatment of benign hyperplasia of the prostate].
Clemente Ramos L; Burgos Revilla FJ; Fernández Fernández E; Jiménez Cidre M; Cruz Guerra N; Escudero Barrilero A
Arch Esp Urol; 1997 Sep; 50(7):773-80. PubMed ID: 9412383
[TBL] [Abstract][Full Text] [Related]
10. Thermosensitive stent (Memotherm) for the treatment of benign prostatic hyperplasia.
Gottfried HW; Schlmers HP; Gschwend J; Brändle E; Hautmann RE
Arch Esp Urol; 1994 Nov; 47(9):933-43; discussion 943-6. PubMed ID: 7530951
[TBL] [Abstract][Full Text] [Related]
11. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
12. A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results.
Oesterling JE
J Androl; 1991; 12(6):423-8. PubMed ID: 1722799
[TBL] [Abstract][Full Text] [Related]
13. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
14. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
Thalmann GN; Mattei A; Treuthardt C; Burkhard FC; Studer UE
J Urol; 2002 Jun; 167(6):2496-501. PubMed ID: 11992066
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
16. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
[TBL] [Abstract][Full Text] [Related]
17. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
18. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
Djavan B; Roehrborn CG; Shariat S; Ghawidel K; Marberger M
J Urol; 1999 Jan; 161(1):139-43. PubMed ID: 10037386
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.
Schulman CC; Lock TM; Buzelin JM; Boeminghaus F; Stephenson TP; Talja M;
J Urol; 2001 Oct; 166(4):1358-63. PubMed ID: 11547074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
